24 Hrs
Source:
The Guardian
Weekly diabetes injection lowers blood sugar and weight
A new triple-action weekly injection called retatrutide has shown promising results in a phase 3 trial for type 2 diabetes, significantly reducing blood sugar levels and body weight. The drug, which mimics three gut hormones, led to an average weight loss of over 11% and notable decreases in HbA1c compared to placebo. Most side effects were mild, and further research is ongoing to compare its effectiveness with existing therapies.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)